Literature DB >> 18931335

Airflow limitation in smokers is associated with subclinical atherosclerosis.

Hiroshi Iwamoto1, Akihito Yokoyama, Yoshihiro Kitahara, Nobuhisa Ishikawa, Yoshinori Haruta, Kiminori Yamane, Noboru Hattori, Hitoshi Hara, Nobuoki Kohno.   

Abstract

RATIONALE: Chronic obstructive pulmonary disease (COPD) is associated with increased morbidity and mortality from cardiovascular disease. Although a close association between COPD and atherosclerosis has been speculated, such scientific information is limited.
OBJECTIVES: To evaluate subclinical atherosclerosis in smokers with airflow limitation.
METHODS: The subjects of this study were healthy middle-aged men. Smokers with airflow limitation (n = 61) and age-matched control smokers (n = 122) and control never-smokers (n = 122) without airflow limitation were included in the present study. Subjects with diabetes, acute infection, and respiratory disease other than COPD were excluded beforehand. All subjects underwent chest radiogram, spirometry, blood sampling, and carotid ultrasonography. We determined carotid intima-media thickness and focal atheromatous plaque as indicators of subclinical atherosclerosis.
MEASUREMENTS AND MAIN RESULTS: Mean carotid intima-media thickness was greater in smokers with airflow limitation than in control smokers (P < 0.01) and control never-smokers (P < 0.005). Focal carotid plaque was significantly more prevalent in smokers with airflow limitation than in control never-smokers (P < 0.005). Multivariate analyses showed significant associations between thickened intima-media thickness and decreased percent predicted FEV(1) (P = 0.001) and between plaque and log(10) C-reactive protein (P = 0.013) independent of age, pack-years of smoking, body mass index, peripheral mean arterial pressure, heart rate, glucose, and low-density lipoprotein cholesterol.
CONCLUSIONS: Smokers with airflow limitation had exaggerated subclinical atherosclerosis. This study suggests that middle-aged men who are susceptible to COPD may also be susceptible to vascular atherosclerosis by smoking, and atherosclerotic change starts early in the disease process of COPD.

Entities:  

Mesh:

Year:  2008        PMID: 18931335     DOI: 10.1164/rccm.200804-560OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  43 in total

Review 1.  Chronic obstructive pulmonary disease: consequences beyond the lung.

Authors:  Dinesh Shrikrishna; Nicholas S Hopkinson
Journal:  Clin Med (Lond)       Date:  2012-02       Impact factor: 2.659

2.  Activation of the TLR4 signaling pathway and abnormal cholesterol efflux lead to emphysema in ApoE-deficient mice.

Authors:  Monica Goldklang; Polina Golovatch; Tina Zelonina; Jordis Trischler; Daniel Rabinowitz; Vincent Lemaître; Jeanine D'Armiento
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2012-03-23       Impact factor: 5.464

3.  Pulmonary function and CT biomarkers as risk factors for cardiovascular events in male lung cancer screening participants: the NELSON study.

Authors:  Richard A P Takx; Rozemarijn Vliegenthart; Firdaus A A Mohamed Hoesein; Ivana Išgum; Harry J de Koning; Willem P Th M Mali; Carlijn M van der Aalst; Pieter Zanen; Jan-Willem J Lammers; Harry J M Groen; Eva M van Rikxoort; Michael Schmidt; Bram van Ginneken; Matthijs Oudkerk; Tim Leiner; Pim A de Jong
Journal:  Eur Radiol       Date:  2014-09-03       Impact factor: 5.315

4.  Association between C-reactive protein and carotid plaque in mild-to-moderate idiopathic pulmonary fibrosis.

Authors:  Andrea Sonaglioni; Antonella Caminati; Roberto Lipsi; Michele Lombardo; Sergio Harari
Journal:  Intern Emerg Med       Date:  2021-01-07       Impact factor: 3.397

Review 5.  Defining COPD-Related Comorbidities, 2004-2014.

Authors:  Carlos H Martinez; David M Mannino; Miguel J Divo
Journal:  Chronic Obstr Pulm Dis       Date:  2014-05-06

Review 6.  Heart-lung interaction via infection.

Authors:  Alison Morris
Journal:  Ann Am Thorac Soc       Date:  2014-01

Review 7.  Should mild COPD be treated? Evidence for early pharmacological intervention.

Authors:  Amany F Elbehairy; Katherine A Webb; J Alberto Neder; J Alberto Neder; Denis E O'Donnell
Journal:  Drugs       Date:  2013-12       Impact factor: 9.546

8.  Airflow obstruction, atherosclerosis and cardiovascular risk factors in the AGES Reykjavik study.

Authors:  Gunnar Gudmundsson; Olof Birna Margretardottir; Martin Ingi Sigurdsson; Tamara B Harris; Lenore J Launer; Sigurdur Sigurdsson; Orn Olafsson; Thor Aspelund; Vilmundur Gudnason
Journal:  Atherosclerosis       Date:  2016-07-28       Impact factor: 5.162

9.  A critical role for ABC transporters in persistent lung inflammation in the development of emphysema after smoke exposure.

Authors:  Jarrod Sonett; Monica Goldklang; Piotr Sklepkiewicz; Adam Gerber; Jordis Trischler; Tina Zelonina; Marit Westerterp; Vincent Lemaître; Yasunori Okada; Jeanine D'Armiento
Journal:  FASEB J       Date:  2018-06-15       Impact factor: 5.191

10.  Emphysema is associated with increased inflammation in lungs of atherosclerosis-prone mice by cigarette smoke: implications in comorbidities of COPD.

Authors:  Gnanapragasam Arunachalam; Isaac K Sundar; Jae-Woong Hwang; Hongwei Yao; Irfan Rahman
Journal:  J Inflamm (Lond)       Date:  2010-07-22       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.